Cambridge, England (ots/PRNewswire) - - Blood Marrow Normalised in 31% (Versus 2%) of Patients, With Manageable Side-Effects Nearly a third (31%) of all bendamustine-treated patients saw all clinical evidence of their advanced chronic lymphocytic leukaemia (CLL) disappear when used as a first-line ...
Otsuka Pharmaceutical Europe Ltd.
Tokyo, Japan and Uxbridge, England (ots/PRNewswire) - Otsuka Pharmaceutical Co., Ltd. and Otsuka Pharmaceutical Europe Ltd. (OPEL) announced today that the European Commission has approved the Marketing Authorisation Application for the company's oral once-daily medication Samsca(TM)(tolvaptan), a selective ...
Construction of the 32.5 MW project to commence in 2009 Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. companies/Order intake Norderstedt (euro adhoc) - Nordex UK's business is continuing to grow in Ireland and Great Britain. The company has now been awarded a contract by its major customer ABO Wind for 13 2.5 MW turbines for the ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 6-month report 27.07.2009 Key financial data for the second quarter and first six months of 2009 Unterpremstaetten, Austria (July 27, 2009) ...
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 6-month report 22.07.2009 In spite of recession, Syzygy AG was able to improve gross sales by 10 per cent to EUR 39.6 m in the period under review. Compared to the ...
Cape Town, South Africa (ots/PRNewswire) - - For Medical Media Outside the US Only Results from the ARTEN* trial presented at the 5th International AIDS Society (IAS) conference in Cape Town, South Africa demonstrated non-inferiority regarding efficacy between Viramune(R) (nevirapine) and ritonavir ...
Construction to begin this week, with production slated for 2010 Investment of $100 million will create 700 direct jobs USA will be the worlds single largest market for wind power in 2010 Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. capital investment Jonesboro / ...
Charlotte, North Carolina (ots/PRNewswire) - - Strong Pretax, Pre-provision Income of US$16 Billion - Another Good Quarter in Capital Markets and Home Loans - Enhanced Capital Strength, Tier 1 Capital Ratio at 11.93 Percent - Extends More Than US$211 Billion in Credit in the Second Quarter - Adds US$4.7 Billion to Credit Loss Reserves Bank of America Corporation today reported second-quarter ...
Vienna (ots/PRNewswire) - - Attitudinal and Behavioural Barriers(1) - Combined with Inability to Recognize Disease Symptoms(1) - Contribute to Delay in Diagnosis and Treatment A new study presented today at a major International medical meeting reveals that approximately two-thirds of physicians in ...
Ten N90/2500 turbines ordered by new customer As Makinsan Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. companies/order intake Norderstedt (euro adhoc) - Following directly on from the award of the "Bergama" 90 MW project, Nordex has now also obtained a further contract from ...
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Company Information 06.07.2009 Büdelsdorf, 06. Juli 2009 - The executive board of freenet AG has resolved today to issue an invitation for expressions of interest ...
Ingelheim, Germany (ots/PRNewswire) - - For Medical Media Outside the US only Boehringer Ingelheim announced today that the European Commission has approved an update of the Summary of Product Characteristics (SmPC) for VIRAMUNE(R) (nevirapine) in the treatment of patients with HIV. The decision followed a positive recommendation by the Committee for Medical ...
Subsidiary established in the growing Turkish market Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. cooperations/Order intake Norderstedt (euro adhoc) - Nordex AG is extending its position in the Turkish market. After establishing a local company based in Istanbul in April 2009, it has now gained a firmly financed contract for a total ...
Basel (ots/PRNewswire) - - For non-US, non-UK and non-Austrian Media Patients with advanced (metastatic) breast cancer will be able to benefit from treatment with Avastin (bevacizumab) as a result of a new broader label recommendation in Europe, Roche announced today. The positive opinion issued by the ...
Hatfield, England (ots/PRNewswire) - - Leading Research-Based Pharmaceutical Company Creates New Manufacturing and Research Jobs in UK Eisai, one of the world's leading pharmaceutical companies, today officially opened its new 'European Knowledge Centre' (the EKC) in Hatfield, Hertfordshire. Committed to developing new medicines for patients ...
Bristol-Myers Squibb and AstraZeneca
Paris and London (ots/PRNewswire) - Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (LSE: AZN) today announced that their marketing authorisation application for ONGLYZA(TM) (saxagliptin) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for the treatment of type 2 diabetes in adults as add-on therapy with metformin, ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. annual report 24.06.2009 [pic] Ad hoc release - 24 June 2009 phion AG published results for financial year 2008/09: Strong growth phase ...
Maidenhead, England (ots/PRNewswire) - - Two-year Data From COMET Study in Early Active Moderate-to-Severe Rheumatoid Arthritis Indicated Sustained Halt of Progressive Joint Damage - New Analyses From ASCEND Study in Ankylosing Spondylitis Indicated Improvement in Patients With and Without Peripheral ...
mSEPT9 biomarker facilitates innovative blood test for colorectal cancer mSEPT9 data published in Clinical Chemistry PRESEPT Study for colorectal cancer screening with mSEPT9 well on track Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this ...
Orlando, Florida (ots/PRNewswire) - Data from the Phase III ZODIAC(1) study in advanced non-small cell lung cancer patients, with the investigational drug vandetanib, were presented today at the American Society of Clinical Oncology (ASCO) meeting in Orlando. Results show that the study met its primary endpoint, ...
Basel, Switzerland (ots/PRNewswire) - - For ex-US Media Only - Phase III ATLAS Study Achieves a New Milestone in Treating Advanced Lung Cancer Roche announced today that the Phase III ATLAS study showed patients with advanced non-small cell lung cancer (NSCLC) who received Avastin(R) (bevacizumab) ...
Stichting Shell Reserves Compensation Foundation and Royal Dutch Shell plc
The Hague, The Netherlands (ots/PRNewswire) - The Hague - Today, the Amsterdam Court of Appeals has declared the Non-U.S. Settlement Agreement concerning the recategorisation by Shell of certain of its oil and gas reserves binding. The agreement provides relief in the amount of US$352.6 million to qualifying non-U.S. shareholders who bought Shell shares on any stock exchange outside the United States from 8 April 1999 ...
Basel, Switzerland (ots/PRNewswire) - - RIBBON-1 Study Confirms Benefit of Avastin in Treating HER2-Negative Breast Cancer - For Non-US, Non-UK and Non-Austrian Media Results from the phase III RIBBON-1 study presented today at ASCO showed that patients with advanced HER2-negative breast cancer ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Research & Development 28.05.2009 » Phase II clinical trial investigating the effectiveness of Intercell´s Vaccine Enhancement (VE) Patch in ...
Huntington Beach, California, and Amsterdam (ots/PRNewswire) - Agendia, a world leader in molecular cancer diagnostics, today announced its strong support of Genentech's Citizen's Petition. Filed on December 5, 2008, Docket No. FDA-2008-P-0638-0001/CP petitions that all in vitro diagnostic tests be held to one ...
SW Umwelttechnik Stoiser & Wolschner AG
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 3-month report 28.05.2009 . Revenue EUR8.4 million - similar to Q1 2005/2006 . Good prospects for Water Conservation business . Results impacted by volatile exchange rates in CSE . EUR41m order backlog points to positive outlook SW Umwelttechnik's ...
Meinl Airports International Ltd.
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. funds St, Helier Jersey (euro adhoc) - AI Airports International Limited has sold all its TAV shares Jersey/Vienna, 27 May 2009 - The Board of Directors of AI Airports International ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. quarterly report 26.05.2009 Vienna, May 26 2009. Compared to the first quarter of 2008 rental income of the CA Immo Group increased by 4.8 % to ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. quarterly report 26.05.2009 Vienna, May 26 2009. The rental income of the CA Immo International Group showed a stable development compared to the ...
Meinl International Power Ltd.
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 25.05.2009 Board of Directors decided on initial repayment to PI certificate holders Jersey/Vienna, May 25, 2009 - The Board of Directors of PI ...